LOUISA WICKS: Open Payments
NPI 1336180074 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 12 payments from 9 companies in 2025. Trend: 2023 $305 · 2024 $310 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Medtronic, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Dexcom G6 Transmitter, Kerendia, ZENPEP, MINIMED 780G, PREVNAR 20, TRELEGY ELLIPTA, CAPLYTA, GVOKE HYPOPEN.
Industry payments across AR — which companies pay providers there.
